Engineered immune cells could transform treatment for autoimmune diseases

Immune cells that are designed to soothe could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions.

AccurKardia Secures $2.7M for Clinical Grade ECG Analytics

What You Should Know: AccurKardia, Inc., a New York-based medical AI software company delivering clinical-grade ECG interpretation software to cardiac monitoring companies raises $2.7M in

June 22, 2023

Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study

DALLAS — A real-world virtual obesity treatment program that involved use of GLP-1 receptor agonists with intensive lifestyle interventions led to robust and sustained weight

October 18, 2023

Merck’s net income for Q1 2024 increases by 69% to $4.76bn

Share this article MSD expects sales for full-year 2024 to be in the range of $63.1bn to $64.3bn. Credit: Michael Vi via Shutterstock. Merck &

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.